Vascular Solutions, Inc. (VASC) news stock charts
Vascular Solutions, Inc. (VASC) Investment Summary:
Vascular Solutions, Inc. (we, us or Vascular) is a medical device company focused on bringing clinically advanced solutions to interventional cardiologists and interventional radiologists worldwide. We were incorporated in the state of Minnesota in December 1996, and we began operations in February 1997. Our main product lines consist of the following: • Hemostat (blood clotting) products, principally consisting of the D-Stat Dry™ hemostat, a topical thrombin-based pad with a bandage used to control surface bleeding, and the D-Stat® Flowable, a thick yet flowable thrombin-based mixture for preventing bleeding in subcutaneous pockets, • Extraction catheters, principally consisting of the Pronto® V3 extraction catheter, a mechanical system for the removal of soft thrombus from arteries, • Vein products, principally cons ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f02%2f05%2f0000897101-08-000253.html#FIS_BUSINESS"www.vascularsolutions.com
266 Employees
Founded in 1996
VASCULAR SOLUTIONS INC (VASC:NASDAQ)
LAST $9.31 USD
CHANGE TODAY -0.09 -0.96%
VOLUME 38.7K
As of 8:10 PM 03/12/10 All times are local (Market data is delayed by at least 15 minutes).
Snapshot of VASCULAR SOLUTIONS INC (VASC)
|
OPEN
$9.31
|
PREVIOUS CLOSE
$9.40
|
|
|
DAY HIGH
$9.41
|
DAY LOW
$9.23
|
|
|
52 WEEK HIGH
03/8/10 - $9.91
|
52 WEEK LOW
04/1/09 - $5.70
|
|
|
MARKET CAP
155.8M
|
AVERAGE VOLUME 10 D
59.7K
|
|
|
EPS TTM
$0.34
|
SHARES OUTSTANDING
16.7M
|
|
|
VASC Does Not Pay Dividends
|
P/E TTM
27.4x
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for VASCULAR SOLUTIONS INC (VASC)
Vascular Mulls Product Acquisitions
02/2/2010
Vascular Solutions, Inc. held its earnings conference call. The company intends to make acquisitions. Howard Root, CEO of the company said: In the fourth quarter, we completed additional animal studies with good results with Magna Seal and received excellent physician feedback and support. While we are not projecting international revenue from the magna seal during 2010, we are very encouraged by the potential of this product in the $500 million existing sealing device market. Beyond the Magna Seal, we are exploring several potential accretive acquisitions of products that fit our sales force call point, and we also continue to plan the next-generation development of our Acolysis therapeutic ultrasound device, which addresses a substantial market for peripheral atherectomy. He added: Okay. Yeah, as far as the acquisitions, I emphasized the accretive part because that's what we're looking at doing. We're not looking at buying R&D projects, we're looking at buying products that are essentially on the market or very close to the market that we can put in our sales force bag and generate sales. When we look at, right now, with the Marine Polymer money in the bank, we're over $21 million cash and no debt, and did a phenomenal job building our cash portfolio in 2009, and we expect that to continue in 2010. Even with the stock repurchase plan, that allows us to have some available cash to make acquisitions without getting anywhere close to a debt position. We also have a $10 million line of credit, but I don't see us as tapping into that. In the last year, we've seen a lot more opportunities to acquire products because, as everyone knows, the financing market for small medical device companies has been closed for some time, or it's very difficult unless you have a real blockbuster device to get through.
Vascular Solutions Inc. expected to Report Q1 2010 Results on April 12, 2010. This event was calculated by Capital IQ (Created on February 2, 2010).
02/2/2010
Vascular Solutions Inc. expected to Report Q1 2010 Results on April 12, 2010. This event was calculated by Capital IQ (Created on February 2, 2010).
Vascular Solutions Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2009; Provides Earnings Guidance for First Quarter and Full Year 2010
02/2/2010
Vascular Solutions Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2009. For the quarter, the company reported total revenue of $18,222,000, operating income of $2,228,000, income before tax of $2,216,000, net income of $1,623,000 or $0.10 per diluted share compared to total revenue of $16,404,000, operating income of $1,457,000, income before tax of $1,477,000, net income of $14,684,000 or $0.90 per diluted share for the same quarter year ago. For the year, the company reported total revenue of $68,427,000, operating income of $8,166,000, income before tax of $8,166,000, net income of $5,378,000 or $0.33 per diluted share compared to total revenue of $61,221,000, operating income of $3,015,000, income before tax of $3,128,000, net income of $16,173,000 or $1.01 per diluted share for the previous year. The company provided earnings guidance for first quarter and full year of 2010. For the full year, the company expects net revenue to increase by approximately 12% from 2009 to between $76 million and $78 million. Corresponding net income on a fully-taxed basis is projected to increase to between $0.53 and $0.57 per fully diluted share, including the one-time litigation gain of $0.13 per share which will be recognized in the first quarter. For the first quarter, the company expects net revenue to be between $17.7 million and $18.0 million. Corresponding net income on a fully-taxed basis for the first quarter is expected to be between $0.20 and $0.21 per fully diluted share, including the one-time litigation gain of $0.13 per share.
Vascular Solutions, Inc. financial resources
VASC Competitors
| Company | Last | Change |
| Bovie Medical Corp | $7.58 USD | +0.04 |
| Endologix Inc | $3.61 USD | -0.04 |
| Kensey Nash Corp | $22.27 USD | -0.40 |
| LeMaitre Vascular Inc | $4.73 USD | +0.062 |
| Staar Surgical Co | $3.63 USD | -0.07 |
| Market data is delayed at least 15 minutes. | ||
Industry Analysis
| Valuation | VASC | Industry Range |
| Price/Earnings | 28.5x |
|
| Price/Sales | 2.2x |
|
| Price/Book | 3.8x |
|
| Price/Cash Flow | 29.0x |
|
| TEV/Sales | 2.0x |
|
|
VASC |
||
|
VASC transactions
| Type Date |
Target |
|
Buyback
January 29, 2010 |
-- |
More Recent Financial News About Vascular Solutions, Inc.
Vascular Solutions 4Q profit falls on taxes
2010-03-01 04:36:35
Quote: MINNEAPOLIS (AP) -- Medical device company Vascular Solutions Inc. said Tuesday its fourth-quarter profit plunged without the year-ago period's income tax gain, but sales of catheter and bleeding-control products rose.The company earned $1.6 million, or 10 cents per share, compared with profit of $14.7 million, or 90 cents per share, during the same period a year prior. Revenue rose 11 percent to $18.2 million from $16.4 million.Analysts polled by Thomson Reuters expected profit of 10 cents per ...Read article
Vascular Solutions expects profit boost in 2010
2010-03-01 04:36:34
Quote: MINNEAPOLIS (AP) -- Medical device company Vascular Solutions Inc. said Tuesday expects a profit and revenue boost in 2010 and set its outlook above Wall Street expectations.The company expects profit between 53 cents and 57 cents per share, including 13 cents in litigation charges. The company expects revenue between $76 million and $78 million.Analysts polled by Thomson Reuters expect profit of 43 cents per share on revenue of $75.9 million. Thomson estimates normally exclude one-time charges ...Read article
Vascular Solutions to Participate in the RBC Capital Markets 2010 Healthcare Conference
2010-02-26 09:07:15
Quote: VASCNews) today announced that the Company is scheduled to participate in the RBC Capital Markets 2010 Healthcare Conference in New York City on Tuesday, March 2, 2010 at 10:00am (EST).http://www.vascularsolutions.com and click on the "IR Conferences" icon a few minutes prior to start time to download any necessary software.About RBC Capital Marketshttp://www.rbccm.com/.About Vascular SolutionsVascular Solutions, Inc. is an innovative medical device company that focuses on developing unique clin...Read article
Vascular Solutions Announces Record Fourth Quarter Results; Net Revenue Increases 11% to Record $18.2 Million; Net Income of $0.10 Per Share
2010-02-25 07:52:23
Quote: Highlights of the fourth quarter and other recent events include:Commenting on the results, Vascular Solutions' Chief Executive Officer Howard Root said: "Once again, in the fourth quarter Vascular Solutions demonstrated double digit percentage sales growth and rapid new product innovation, while at the same time adding substantially to our net income and our positive cash flow. We expect this progress to continue in 2010, with substantial projected growth from the recent launch of our innovativ...Read article
Vascular Solutions to Participate in the RBC Capital Markets 2010 Healthcare Conference
2010-02-24 03:40:54
Quote: VASCNews) today announced that the Company is scheduled to participate in the RBC Capital Markets 2010 Healthcare Conference in New York City on Tuesday, March 2, 2010 at 10:00am (EST).http://www.vascularsolutions.com and click on the "IR Conferences" icon a few minutes prior to start time to download any necessary software.About RBC Capital Marketshttp://www.rbccm.com/.About Vascular SolutionsVascular Solutions, Inc. is an innovative medical device company that focuses on developing unique clin...Read article
Vascular Solutions gets $3.5M payment from lawsuit
2010-02-16 06:17:01
Quote: MINNEAPOLIS (AP) -- Medical device maker Vascular Solutions Inc. said Thursday it received $3.5 million from Marine Polymer Technologies after a court ruled Marine Polymer employees made false statements about Vascular Solutions products.Vascular Solutions said a jury found Marine Polymer representatives made false statements about D-Stat hemostat products, which are used to reduce bleeding during surgery. The company said it had expected to receive $3.2 million, but the new amount includes inte...Read article
Vascular Solutions Announces Record Fourth Quarter Results; Net Revenue Increases 11% to Record $18.2 Million; Net Income of $0.10 Per Share
2010-02-16 06:17:00
Quote: VASCNews) today reported financial results for the fourth quarter ended December 31, 2009. Highlights of the fourth quarter and other recent events include:Commenting on the results, Vascular Solutions’ Chief Executive Officer Howard Root said: “Once again, in the fourth quarter Vascular Solutions demonstrated double digit percentage sales growth and rapid new product innovation, while at the same time adding substantially to our net income and our positive cash flow. We ex...Read article
Vascular Solutions expects profit boost in 2010
2010-02-16 06:16:59
Quote: MINNEAPOLIS (AP) -- Medical device company Vascular Solutions Inc. said Tuesday expects a profit and revenue boost in 2010 and set its outlook above Wall Street expectations.The company expects profit between 53 cents and 57 cents per share, including 13 cents in litigation charges. The company expects revenue between $76 million and $78 million.Analysts polled by Thomson Reuters expect profit of 43 cents per share on revenue of $75.9 million. Thomson estimates normally exclude one-time charges ...Read article
Vascular Solutions 4Q profit falls on taxes
2010-02-16 06:16:59
Quote: MINNEAPOLIS (AP) -- Medical device company Vascular Solutions Inc. said Tuesday its fourth-quarter profit plunged without the year-ago period's income tax gain, but sales of catheter and bleeding-control products rose.The company earned $1.6 million, or 10 cents per share, compared with profit of $14.7 million, or 90 cents per share, during the same period a year prior. Revenue rose 11 percent to $18.2 million from $16.4 million.Analysts polled by Thomson Reuters expected profit of 10 cents per ...Read article
Vascular Solutions Announces Record Fourth Quarter Results; Net Revenue Increases 11% to Record $18.2 Million; Net Income of $0.10 Per Share
2010-02-03 04:45:26
Quote: VASCNews) today reported financial results for the fourth quarter ended December 31, 2009. Highlights of the fourth quarter and other recent events include:Commenting on the results, Vascular Solutions’ Chief Executive Officer Howard Root said: “Once again, in the fourth quarter Vascular Solutions demonstrated double digit percentage sales growth and rapid new product innovation, while at the same time adding substantially to our net income and our positive cash flow. We ex...Read article
Q4 2009 Vascular Solutions, Inc. Earnings Release - After Market Close
2010-02-03 04:45:26
Quote: Read article
Vascular Solutions 4Q profit falls on taxes
2010-02-03 04:45:25
Quote: MINNEAPOLIS (AP) -- Medical device company Vascular Solutions Inc. said Tuesday its fourth-quarter profit plunged without the year-ago period's income tax gain, but sales of catheter and bleeding-control products rose.The company earned $1.6 million, or 10 cents per share, compared with profit of $14.7 million, or 90 cents per share, during the same period a year prior. Revenue rose 11 percent to $18.2 million from $16.4 million.Analysts polled by Thomson Reuters expected profit of 10 cents per ...Read article
VASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Sta
2010-02-03 04:45:25
Quote: Item 2.02.Results of Operations and Financial Condition
The following information is being "furnished" in accordance with Item 2.02 of
Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended ("Exchange Act"), or otherwise
subject to the liabilities of that section, nor shall it be deemed to be
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, exce...Read article
Vascular Solutions expects profit boost in 2010
2010-02-03 04:45:24
Quote: MINNEAPOLIS (AP) -- Medical device company Vascular Solutions Inc. said Tuesday expects a profit and revenue boost in 2010 and set its outlook above Wall Street expectations.The company expects profit between 53 cents and 57 cents per share, including 13 cents in litigation charges. The company expects revenue between $76 million and $78 million.Analysts polled by Thomson Reuters expect profit of 43 cents per share on revenue of $75.9 million. Thomson estimates normally exclude one-time charges ...Read article
Vascular Solutions Receives $3.5 Million as Payment of Monetary Judgment in Litigation With Marine Polymer Technologies
2010-01-22 02:46:58
Quote: This payment followed a two-week trial held in April 2008 with the jury finding that five statements made by Marine Polymer Technologies representatives regarding Vascular Solutions' D-Stat® hemostat products were false, followed by the decision of the First Circuit Court of Appeals in December 2009 affirming liability and modifying the amount of damages."We are pleased to have this matter concluded and to have finally received payment for the damages incurred," commented Howard Root, CEO of ...Read article
Vascular Solutions gets $3.5M payment from lawsuit
2010-01-22 02:46:57
Quote: MINNEAPOLIS (AP) -- Medical device maker Vascular Solutions Inc. said Thursday it received $3.5 million from Marine Polymer Technologies after a court ruled Marine Polymer employees made false statements about Vascular Solutions products.Vascular Solutions said a jury found Marine Polymer representatives made false statements about D-Stat hemostat products, which are used to reduce bleeding during surgery. The company said it had expected to receive $3.2 million, but the new amount includes inte...Read article
VASCULAR SOLUTIONS INC Files SEC form 8-K, Other Events
2010-01-22 02:46:57
Quote: VASCULAR SOLUTIONS INCRequest a Trial to NEW EDGAR Online Pro
Form
8-K for
VASCULAR SOLUTIONS INC
21-Jan-2010Other EventsPrivacy PolicyAbout Our AdsTerms of ServiceCopyright/IP PolicySend FeedbackSEC
Filing data and information provided by EDGAR Online,
Inc.
(1-800-416-6651). All information provided "as is"
for informational purposes
only, not intended for trading purposes or advice.
Neither Yahoo! nor any of
independent providers is liable for any informational
errors, incompleteness,
or delay...Read article
InPlay: Vascular Solutions receives $3.5 million as payment of monetary judgment in litigation with Marine Polymer Technologies
2010-01-22 02:46:57
Keywords: market update, investing education, financial advice, financial planning
Quote: Read article
Vascular Solutions, Inc. Earnings Call scheduled for Tue, Feb 2
2010-01-20 03:06:27
Quote: Call DetailsVascular Solutions, Inc. Earnings Conference Call (Q4 2009)Scheduled
to start Tue, Feb 2, 2010, 4:30 pm EasternAfter
the event has finished, the audio will be availablefrom
this page until Thu, Feb 3, 2011About Vascular Solutions, Inc.VASC)Vascular Solutions, Inc., a medical device company, develops solutions to interventional cardiologists and interventional radiologists worldwide. It provides Hemostat products, including D-Stat Dry hemostat, a topical thrombin-based pad with a band...Read article
VASCULAR SOLUTIONS INC Files SEC form 8-K, Change in Directors or Principal Officers
2010-01-07 02:58:37
Quote: Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 31, 2009, Vascular Solutions, Inc. ("Company") and James H.
Quackenbush, the Company's Vice President of Manufacturing, entered into a
Separation Agreement and General Release ("Separation Agreement") that sets
forth the terms and conditions under which Mr. Quackenbush and the Company will
terminate Mr. Quackenbush's...Read article
Would you like to leave a comment about Vascular Solutions, Inc. VASC
Find out what social network information about Vascular Solutions, Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Vascular Solutions, Inc.'s Stock there is more great penny stock and market information at Realpennies